RecruitingPhase 2NCT06226883
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Sponsor: Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Johnson City, TN · +24 more sites
2 recruiting crohn's disease studies with a site in Johnson City, TN.
Sponsor: Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Johnson City, TN · +24 more sites
Sponsor: AbbVie
Johnson City, TN · +63 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.